Importance of Molecular Tests for Lung Cancer | Dr. Chandrakanth MV

In this insightful video, Dr. Chandrakanth MV, a cancer specialist at Narayana Hospital, Howrah, explains the critical role of molecular tests in the diagnosis and treatment of lung cancer. These tests, which analyze genetic mutations, have revolutionized the way doctors approach lung cancer treatment. Molecular Tests: Key to Tailored Lung Cancer Treatment Molecular testing is one of the most important steps in diagnosing and treating lung cancer. Dr. Chandrakanth emphasizes that molecular tests are typically conducted on a biopsy sample, which is preserved in a paraffin block. This preservation technique allows the biopsy to remain viable for up to 5-10 years, enabling doctors to conduct various genetic and molecular tests on it. Understanding Genetic Mutations in Lung Cancer Lung cancer can be caused by genetic mutations, and understanding which specific genes are defective in a patient's cancer is critical for choosing the right treatment. Dr. Chandrakanth mentions that there are around 10-12 key genes that should be tested for in lung cancer patients. These genes directly impact how cancer behaves and how it responds to certain treatments. Personalized Treatment with Molecular Testing Once the defective genes are identified, doctors can tailor the treatment plan to the specific genetic characteristics of the cancer. This is where targeted therapy comes into play, as different medications are available for each specific genetic mutation. By conducting molecular tests, doctors can offer personalized treatment, significantly improving a patient’s chances of successful treatment. Liquid Biopsy: A Game-Changer in Cancer Diagnosis In addition to traditional biopsy samples, Dr. Chandrakanth highlights the growing use of liquid biopsy. This innovative method allows for the detection of genetic mutations through a blood test, making it a less invasive and faster way to conduct molecular testing. Liquid biopsies are becoming an essential part of lung cancer diagnosis and help identify mutations that may not be detected through a tissue biopsy alone. The Future of Lung Cancer Treatment Molecular testing is transforming the landscape of lung cancer treatment, moving away from the old "one-size-fits-all" approach. With genetic testing and liquid biopsy, doctors are now able to personalize the care for each patient, improving the overall effectiveness of treatments like targeted therapies and immunotherapy. A Call for Molecular Testing in Lung Cancer Dr. Chandrakanth urges all patients undergoing lung cancer treatment to request molecular testing to identify genetic mutations. This vital information can help doctors decide on the most effective treatment plan, ultimately improving outcomes for lung cancer patients. #LungCancer #MolecularTests #GeneticTesting #LiquidBiopsy #LungCancerTreatment #CancerDiagnosis #PersonalizedTreatment #TargetedTherapy #DrChandrakanthMV #NarayanaHospitalHowrah #CancerSpecialist #LungCancerCare #GeneticMutations #CancerAwareness #biopsymyths Timestamp : 00:00 - Introduction of Doctor 00:15 - Discussion starts about test for lung cancer 00:25 - Talk about Molecular test 01:29 - Performed on Molecular test 01:46 - Treatment of Lung Cancer